Haemorrhagic disease of the newborn: Difference between revisions
No edit summary |
No edit summary |
||
Line 42: | Line 42: | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources} | {{WikiDoc Sources}} |
Revision as of 20:35, 31 July 2009
Haemorrhagic disease of the newborn | |
Vitamin K1 | |
ICD-10 | P53 |
ICD-9 | 776.0 |
DiseasesDB | 29544 |
eMedicine | ped/966 |
MeSH | D006475 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Haemorrhagic disease of the newborn is a coagulation disturbance in newborns due to vitamin K deficiency. As a consequence of vitamin K deficiency there is an impaired production of coagulation factors II, VII, IX, X, C and S by the liver.
Causes
Newborns are relatively vitamin K deficient for a variety of reasons. They have low vitamin K stores at birth, vitamin K passes the placenta poorly, the levels of vitamin K in breast milk are low and the gut flora has not yet been developed (vitamin K is normally produced by bacteria in the intestines).
Presentation
The disease causes an increased risk of bleeding. The most common sites of bleeding are the umbilicus, mucous membranes, gastrointestinal tract, circumcision and venipunctures.
Treatment
Treatment consists of vitamin K supplementation. This is often given prophylactically newborns shortly after birth.
Template:Certain conditions originating in the perinatal period Template:SIB